Medicover acquires leading genetics laboratory in Germany

Report this content

Medicover has signed an agreement to acquire the centre for genetic diagnostics of Dr. Klein, Dr. Rost and colleagues as well as its affiliate IMGM, both located in Martinsried, near Munich, Germany. The laboratory has a strong position within genetic testing, pathology, transfusion medicine, microbiology and virology and will accordingly enhance Medicover’s offering within these areas. The acquisition will as well create a platform for further expansion in southern Germany.

Revenue for the laboratory amounted to around 17 million euro in 2017 with a total number of employees of 160. The transaction is subject to merger control clearance and regulatory approvals with closing expected in January 2019.

For further information, please contact:

Paula Treutiger, Corporate Communications and Investor Relations Director

+46 733 666 599 paula.treutiger@medicover.com

Medicover is a leading international healthcare and diagnostic services company and was founded in 1995. Medicover operates a large number of ambulatory clinics, hospitals, specialty-care facilities and laboratories and the largest markets are Poland and Germany. In 2017, Medicover had revenues around €580 million and 15,900 employees. For more information, go to www.medicover.com